Skip to main content
Show — Main navigation Hide — Main navigation
  • Home
  • About
    • The Chair
    • Inquiry Team
    • Expert Groups
    • Inquiry Intermediaries
    • Core Participants
    • Legal Representatives
    • Financial Reports
  • Approach
    • Terms of reference
    • List of Issues
    • Statements of approach
    • Inquiry Principles
  • News
    • News
    • Newsletter Archive
  • Reports
    • Compensation Framework Study
    • First Interim Report
    • Second Interim Report
    • The Inquiry Report
  • Publication Day
  • Evidence
    • Evidence
    • Hearings Archive
  • Compensation
  • Support
    • Confidential Psychological Support
    • Interim Payments
    • Support Groups
    • Get in touch
    • Infected Blood Support Schemes
    • Treatment and aftercare
    • Medical Evidence
    • Expenses Guidance
Accessibility Tool
  • Zoom in
  • Zoom out
  • Reset
  • Contrast
  • Accessibility tool
Get in touch

Quick Exit

Subscribe to Search results

Due to a large research grant Treloar's was able to supply students with much more blood product than their home clinicians.

Published on: 16 July, 2024

At a time of growing concerns about concentrates manufactured in the USA from large pools, no cryoprecipitate was used at Treloar's in 1982.

Published on: 16 July, 2024

At a time of growing concerns about concentrates manufactured in the USA from large pools, no cryoprecipitate was used at Treloar's in 1983.

Published on: 16 July, 2024

Conversation between Dr Aronstam, Adrian Goodyear and some boys of Treloar's where Dr Aronstam expressed his concern and emotions regarding the boys having been infected with HIV.

Published on: 16 July, 2024

Dr Aronstam told Adrian Goodyear, who attended Treloar's, that he had contracted HIV.

Published on: 16 July, 2024

Adrian Goodyear, a boy from Treloar's, stated Dr Aronstam's guilt towards the boys having contracted HIV and that the PHLS let him down by setting him up.

Published on: 16 July, 2024

At Treloar's NHS Concentrate was used a lot less compared to commercial concentrates.

Published on: 16 July, 2024

Richard Warwick, a student at Treloar's, stated that "they were crazy about prophylactics at Treloars' and prophylaxis was used 'like every day'.

Published on: 16 July, 2024

Treloar's were able to arrange to keep a pupil on one type of treatment for the 1975 hepatitis study.

Published on: 16 July, 2024

It was acknowledged there was a risk that the hepatitis might be Hepatitis B, even though screening had improved since RIA testing.

Published on: 16 July, 2024

It was stated that there were a variety of responses to exposure to hepatitis B virus in human beings: acute hepatitis, asymptomatic infection with little or no liver damage, chronic hepatitis, persistent production of hepatitis B viral antigen and antibody to surface antigens.

Published on: 16 July, 2024

Alter et al showed that after excluding commercial and Hepatitis B antigen positive donors, post-transfusion hepatitis remained.

Published on: 16 July, 2024

Dr Rainsford identified that the hepatitis of a boy under his care at Treloar's was almost certainly caused by plasma.

Published on: 16 July, 2024

There was a hepatitis outbreak at Treloar's in 1975.

Published on: 16 July, 2024

Dr Arblaster asked a parent of a Treloar's student to reconsider their decision to withdraw consent for him to be treated with "new material".

Published on: 16 July, 2024

The results of a third prophylaxis trial undertaken at Treloar's were reported to UKHCDO Directors.

Published on: 16 July, 2024

A trial was carried out at Treloar's aimed to see if prophylaxis would improve the radiological appearance of joints and "more particularly have any influence on haemophilic cysts." It was stated that there could be a significant lessening in the number of bleeds, but to achieve this, it would require amounts of concentrate which were simply unavailable in such quantities.

Published on: 16 July, 2024

Andrew Quinn, a pupil at Treloar's, was selected to receive Factor 8 prophylactically for a year. He was never advised that there were any risks attached to receiving Factor 8.

Published on: 16 July, 2024

From 1970 to 1973, Dr Rainsford studied the incidence of serum hepatitis. The aim was to see if there was any pattern to the way in which antibodies and antigens to serum hepatitis correlated with clinical illness, the frequency of transfusion and the presence of antigens in the blood products with which they were being treated.

Published on: 16 July, 2024

It was acknowledged that recent research had shown that viruses other than Hepatitis A and B may have caused significant amount of post-transfusion hepatitis.

Published on: 16 July, 2024

Pagination

  • First page First
  • Previous page Previous
  • …
  • Page 1998
  • Page 1999
  • Page 2000
  • Page 2001
  • Current page 2002
  • Page 2003
  • Page 2004
  • Page 2005
  • Page 2006
  • …
  • Next page Next
  • Last page Last

Inquiry

  • Home
  • About
  • Approach
  • Participate
  • News
  • Evidence
  • Support
  • Get in touch

Legal

  • Terms & Conditions
  • Cookies notice
  • Privacy Notice
  • Accessibility tool

Address

Infected Blood Inquiry
5th Floor
Aldwych House
71-91 Aldwych
London
WC2B 4HN
 
Images of individuals on the website are used with the agreement of those featured or are stock images.

Follow us

© Crown copyright. Licensed under the Open Government Licence v3.0 except where otherwise stated.